Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The United Laboratories International Holdings ( (HK:3933) ) has issued an announcement.
The United Laboratories International Holdings Limited has announced its upcoming Annual General Meeting (AGM) scheduled for June 25, 2025. Key agenda items include the adoption of financial statements, declaration of final and special dividends, re-election of directors, and the re-appointment of Deloitte Touche Tohmatsu as auditors. The meeting will also consider a resolution to authorize the board to allot and issue additional shares, reflecting the company’s strategic focus on growth and shareholder value.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development, manufacturing, and distribution of pharmaceutical products.
YTD Price Performance: -9.81%
Average Trading Volume: 11,748
Technical Sentiment Signal: Sell
Current Market Cap: $3.17B
For an in-depth examination of 3933 stock, go to TipRanks’ Stock Analysis page.